(Q34522536)

English

Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Amir Halkin

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gad Keren

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

126-134

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Elevated Levels of Interleukin-6 in Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Induction of in vitro human lymphocyte migration by interleukin 3, interleukin 4, and interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Captopril and L-arginine have a synergistic cardioprotective effect in ischemic-reperfusion injury in the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Improvement of coronary flow reserve after long-term therapy with enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Enalapril improves arterial elastic properties in rats with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Captopril administration reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIa in early postmyocardial infarction stage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

The Interrelation between carotid, femoral and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. ACE inhibitors in the management of congestive heart failure: comparative economic data

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Evidence-based medicine: an incomplete method for informing treatment choices

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin and ACE-inhibitors: for wedding or funeral?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901001-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(01)01001-4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34522536&oldid=1967541642"